These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21130400)

  • 1. [Oncologic outcomes after radical prostatectomy: French validation of the D'Amico risk group classification].
    Ouzzane A; Koenig P; Ballereau C; Zini L; Ghoneim T; Maladry F; Fantoni JC; Biserte J; Leroy X; Villers A
    Prog Urol; 2010 Dec; 20(13):1206-12. PubMed ID: 21130400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary evaluation of the D'amico risk classification of prostate cancer.
    Hernandez DJ; Nielsen ME; Han M; Partin AW
    Urology; 2007 Nov; 70(5):931-5. PubMed ID: 18068450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE.
    Mitchell JA; Cooperberg MR; Elkin EP; Lubeck DP; Mehta SS; Kane CJ; Carroll PR
    J Urol; 2005 Apr; 173(4):1126-31. PubMed ID: 15758720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy.
    Boorjian SA; Karnes RJ; Rangel LJ; Bergstralh EJ; Blute ML
    J Urol; 2008 Apr; 179(4):1354-60; discussion 1360-1. PubMed ID: 18289596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformal radiotherapy for detectable PSA following radical prostatectomy: efficacy and predictive factors of recurrence.
    Delongchamps NB; Zerbib M; Mejean A; Rouach Y; Debre B; Peyromaure M
    Can J Urol; 2009 Oct; 16(5):4813-9. PubMed ID: 19796456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological findings and prostate-specific antigen outcomes after laparoscopic radical prostatectomy for high-risk prostate cancer.
    Ploussard G; Salomon L; Allory Y; Terry S; Vordos D; Hoznek A; Abbou CC; Vacherot F; de la Taille A
    BJU Int; 2010 Jul; 106(1):86-90. PubMed ID: 19930177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer.
    Walz J; Chun FK; Klein EA; Reuther A; Saad F; Graefen M; Huland H; Karakiewicz PI
    J Urol; 2009 Feb; 181(2):601-7; discussion 607-8. PubMed ID: 19084864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Carcinologic outcomes after radical prostatectomy in 81 high-risk patients].
    Carcenac A; Arroua F; Gaudart J; Ragni E; Rossi D; Bastide C
    Prog Urol; 2010 May; 20(5):356-63. PubMed ID: 20471580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk-adjusted hazard rates of biochemical recurrence for prostate cancer patients after radical prostatectomy.
    Walz J; Chun FK; Klein EA; Reuther A; Graefen M; Huland H; Karakiewicz PI
    Eur Urol; 2009 Feb; 55(2):412-19. PubMed ID: 19027223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing D'Amico risk groups in radical prostatectomy through the addition of magnetic resonance imaging data.
    Algarra R; Zudaire B; Tienza A; Velis JM; Rincón A; Pascual I; Zudaire J
    Actas Urol Esp; 2014 Nov; 38(9):594-9. PubMed ID: 24791621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of preoperative nomogram for disease recurrence within 5 years after laparoscopic radical prostatectomy for prostate cancer.
    Kattan MW; Yu C; Salomon L; Vora K; Touijer K; Guillonneau B
    Urology; 2011 Feb; 77(2):396-401. PubMed ID: 20970840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial comment on: Risk-adjusted hazard rates of biochemical recurrence for prostate cancer patients after radical prostatectomy.
    Bastian PJ
    Eur Urol; 2009 Feb; 55(2):420. PubMed ID: 19027222
    [No Abstract]   [Full Text] [Related]  

  • 13. The prognostic significance of capsular incision into tumor during radical prostatectomy.
    Preston MA; Carrière M; Raju G; Morash C; Doucette S; Gerridzen RG; Bella AJ; Eastham JA; Scardino PT; Cagiannos I
    Eur Urol; 2011 Apr; 59(4):613-8. PubMed ID: 21195540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of prostate gland weight in robot assisted laparoscopic radical prostatectomy.
    Link BA; Nelson R; Josephson DY; Yoshida JS; Crocitto LE; Kawachi MH; Wilson TG
    J Urol; 2008 Sep; 180(3):928-32. PubMed ID: 18635217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncologic outcome and patterns of recurrence after salvage radical prostatectomy.
    Paparel P; Cronin AM; Savage C; Scardino PT; Eastham JA
    Eur Urol; 2009 Feb; 55(2):404-10. PubMed ID: 18639970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors for positive surgical margins and their locations after robot-assisted laparoscopic radical prostatectomy.
    Coelho RF; Chauhan S; Orvieto MA; Palmer KJ; Rocco B; Patel VR
    Eur Urol; 2010 Jun; 57(6):1022-9. PubMed ID: 20163911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biostatistical modeling using traditional preoperative and pathological prognostic variables in the selection of men at high risk for disease recurrence after radical prostatectomy for prostate cancer.
    Bauer JJ; Connelly RR; Seterhenn IA; Deausen J; Srivastava S; McLeod DG; Moul JW
    J Urol; 1998 Mar; 159(3):929-33. PubMed ID: 9474185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.
    Ward JF; Slezak JM; Blute ML; Bergstralh EJ; Zincke H
    BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial comment on: Risk-adjusted hazard rates of biochemical recurrence for prostate cancer patients after radical prostatectomy.
    Hakenberg OW
    Eur Urol; 2009 Feb; 55(2):421. PubMed ID: 19027224
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer.
    Nelson BA; Shappell SB; Chang SS; Wells N; Farnham SB; Smith JA; Cookson MS
    BJU Int; 2006 Jun; 97(6):1169-72. PubMed ID: 16686706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.